275 related articles for article (PubMed ID: 16454137)
1. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
Syed NN; Khurshid M
J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
[TBL] [Abstract][Full Text] [Related]
3. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
Ford CD; Asch J; Pulsipher M; Petersen FB
Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959
[No Abstract] [Full Text] [Related]
4. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
Maclean R; Meiklejohn D; Soutar R
Br J Haematol; 1996 Mar; 92(3):768-9. PubMed ID: 8616054
[No Abstract] [Full Text] [Related]
5. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
6. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
[TBL] [Abstract][Full Text] [Related]
7. [Fludarabine and fatal hemolytic anemia].
López L; del Villar V; Pascual T
Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
[No Abstract] [Full Text] [Related]
8. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
Hamblin TJ; Orchard JA; Myint H; Oscier DG
J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
[No Abstract] [Full Text] [Related]
9. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
[No Abstract] [Full Text] [Related]
10. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
Vick DJ; Byrd JC; Beal CL; Chaffin DJ
Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
[TBL] [Abstract][Full Text] [Related]
11. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
[No Abstract] [Full Text] [Related]
12. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
Leach M; Parsons RM; Reilly JT; Winfield DA
Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
[TBL] [Abstract][Full Text] [Related]
14. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
16. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
Garratty G; Petz LD
Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948
[No Abstract] [Full Text] [Related]
17. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Sen K; Kalaycio M
Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
[No Abstract] [Full Text] [Related]
18. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
Churn M; Clough V
Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
Hocepied AM; Falkson CI; Falkson G
S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
[Next] [New Search]